Rebound Therapeutics Corp — Form D
Rebound Therapeutics Corp of IRVINE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-07-28. The offering totals $16.5M, of which $16.5M was reported sold. Industry: Other Technology.
Offering
- Filed: 2017-07-28
- Form: D
- Accession: 0001662622-17-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $16.5M
- Amount sold: $16.5M
- Minimum investment: $5K
- Investors: 49
- Date of first sale: 2017-07-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-291665
Issuer
- Name: Rebound Therapeutics Corp
- CIK: 0001662622
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 13844 ALTON PARKWAY, SUITE 131, IRVINE, CA, 92618
- Phone: 949-581-7250
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Michael R Henson | Director | Irvine, CA |
| Jeffrey J Valko | Director | Irvine, CA |
| Michael R Henson | Executive Officer | Irvine, CA |
| Tracy R Pearson | Executive Officer | IRVINE, CA |
| Jeffrey J Valko | Executive Officer | Irvine, CA |
Other filings by this issuer (1)
More